Committees : ASPH DTC
You are here : Home > Committees : ASPH DTC
Committee Types
Please select an organisation name from the list below to view associated profiles and decisions.
Committee
- ASPH DTC
- East Surrey CCG Medicines Programme Board
- East Surrey MOG
- Epsom St Helier NDAIG
- ESCCG sub-committee of North Place Alliance Clinical Strategy Committee (formerly Clinical Executive
- Guildford and Waverley MOG
- Medicines Optimisation Operational Group (MOOG)
- Not Set
- NW Surrey Medicines Optimisation Group
- Primary Care Medicines Optimisation Clinical reference Group (PCMOCRG)
- RSFT DTC
- SASH DTG
- Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
- Surrey Downs CCG Prescribing Leads Meeting
- Surrey Downs MOG
- Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
- Surrey Heartlands Medicines Optimisation Board (MOB)
- Surrey Heartlands Medicines Safety Committee (MSC)
- Surrey Medicines Commissioners Group
Trust
Profiles (0)
No records returned.
Committee Recommendations (4)
Prometrium agreed as a RED drug for it's licensed indication. An application to the APC for a change in traffic light status was discussed and to be explored by the specialist team.
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
The committee supported the use of nepafenac within its licensed indications. As treatment is short term postoperatively (up to 60 days with a review by the specialist 1 month post operatively) it was agreed that this would be considered as a red drug on the traffic light system.